Palvella Therapeutics (PVLA) Other Gross PP&E Adjustments (2016 - 2023)
Historic Other Gross PP&E Adjustments for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2023 value amounting to -$960000.0.
- Palvella Therapeutics' Other Gross PP&E Adjustments fell 10418.59% to -$960000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$960000.0, marking a year-over-year change of. This contributed to the annual value of -$960000.0 for FY2023, which is 10418.59% down from last year.
- Latest data reveals that Palvella Therapeutics reported Other Gross PP&E Adjustments of -$960000.0 as of Q4 2023, which was down 10418.59% from $22.9 million recorded in Q2 2023.
- Palvella Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $23.9 million during Q4 2020, with a 5-year trough of -$960000.0 in Q4 2023.
- In the last 5 years, Palvella Therapeutics' Other Gross PP&E Adjustments had a median value of $22.6 million in 2020 and averaged $19.4 million.
- In the last 5 years, Palvella Therapeutics' Other Gross PP&E Adjustments soared by 15514.08% in 2020 and then tumbled by 10418.59% in 2023.
- Quarter analysis of 5 years shows Palvella Therapeutics' Other Gross PP&E Adjustments stood at $19.6 million in 2019, then grew by 21.87% to $23.9 million in 2020, then dropped by 4.17% to $22.9 million in 2021, then rose by 0.02% to $22.9 million in 2022, then tumbled by 104.19% to -$960000.0 in 2023.
- Its Other Gross PP&E Adjustments was -$960000.0 in Q4 2023, compared to $22.9 million in Q2 2023 and $22.9 million in Q1 2023.